50m ·
Our #IiKeyvaccine technology is applicable to not only COVID-19 but also the #G4swineflu emerging in China as this technology can vaccinate against select epitopes for any given #infectiousdisease.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
